BROWN RUDNICK LLP for APOTEX CORPORATION
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
S. 1951, H.R. 3700 - Fair Medicaid Drug Payment Act of 2007
Foreign entity interest: Shermfin Inc., the parent company of Apotex Corp., has direct and/or indirect ownership interest in companies that develop, manufacture, and/or sell generic drugs, and therefore has an interest in the issues identified in this report.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HENRY W MENN | — |
Health Issues HCR
H.R. 3610 - Food and Drug Import Safety Act Issues relating to drug pedigrees
Foreign entity interest: Shermfin Inc., the parent company of Apotex Corp., has direct and/or indirect ownership interest in companies that develop, manufacture, and/or sell generic drugs, and therefore has an interest in the issues identified in this report.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HENRY W MENN | — |
Copyright/Patent/Trademark CPT
S. 316 & H.R. 1432, Preserve Access to Affordable Generics Act
Foreign entity interest: Shermfin Inc., the parent company of Apotex Corp., has direct and/or indirect ownership interests in companies that develop, manufacture, and/or sell generic drugs, and therefore has an interest in the issues identified in this report.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HENRY W MENN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.